Obinutuzumab
Update Venetoclax in CLL
Zanubrutinib
Acalabrutinib
CLL Society
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
NCCN Guidelines for Patients
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL